IL6 and myocardial infarction: In research in China, with 263 patients with ST-segment elevation myocardial infarction, the admission level of IL-6 was correlated with cardiovascular mortality for more than 3 years of follow-up.33 Additionally, Murine experiments, with a number suggest that they do not protect the infarction damage with the elimination of IL-6 effects.34